Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-01-30
DOI
10.3389/fmicb.2019.00080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Critical Review of Double-Carbapenem Therapy for the Treatment of Carbapenemase-Producing Klebsiella pneumoniae
- (2018) Ola Mashni et al. ANNALS OF PHARMACOTHERAPY
- In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from United States Hospitals and Comparative Activity of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes
- (2018) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program
- (2018) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects
- (2018) Yutaka Saisho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
- (2018) Jesús Rodríguez-Baño et al. CLINICAL MICROBIOLOGY REVIEWS
- Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia
- (2018) Marco Falcone et al. Expert Opinion on Drug Metabolism & Toxicology
- Management of infections caused by extended-spectrum β–lactamase-producing Enterobacteriaceae: current evidence and future prospects
- (2018) Chau-Chyun Sheu et al. Expert Review of Anti-Infective Therapy
- Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection
- (2018) Maddalena Giannella et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme
- (2018) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae : in vitro activity and a Galleria mellonella model
- (2018) Haifei Yang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections
- (2018) Ting-Ting Geng et al. MEDICINE
- Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis
- (2018) Amber Martin et al. Open Forum Infectious Diseases
- Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
- (2018) Sohita Dhillon DRUGS
- Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms
- (2018) Mariana Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates
- (2018) Pranita D. Tamma et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
- (2018) Lindsay Petty et al. Infection and Drug Resistance
- Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials
- (2018) I-Ling Cheng et al. Journal of Clinical Medicine
- Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality
- (2017) M. Papadimitriou-Olivgeris et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
- (2017) M. Souli et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility
- (2017) Alexandre P. Zavascki et al. Expert Review of Anti-Infective Therapy
- Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation
- (2017) Fiorella Krapp et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new
- (2017) Michael Z. David et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
- (2017) Juan J. Castón et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
- (2017) Matthew Sims et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value
- (2017) A. Oliva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp)
- (2017) Alessandra Oliva et al. JOURNAL OF INFECTION
- The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan
- (2017) Sung-Pin Tseng et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study
- (2017) Shih-Wen Ting et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan
- (2017) Chun-Ming Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance
- (2017) Yee-Huang Ku et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- The drug-resistant bacteria that pose the greatest health threats
- (2017) Cassandra Willyard NATURE
- Therapeutic options for carbapenem-resistant Enterobacteriaceae infections
- (2017) Enrico Maria Trecarichi et al. Virulence
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Double carbapenem therapy (DCT) for bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP): from test tube to clinical practice
- (2017) Veena Venugopalan et al. Infectious Diseases
- Improved Outcomes with Plazomicin (PLZ) Compared with Colistin (CST) in Patients with Bloodstream Infections (BSI) Caused by Carbapenem-resistant Enterobacteriaceae (CRE): Results from the CARE Study
- (2017) James A McKinnell et al. Open Forum Infectious Diseases
- Bloodstream infections caused byKlebsiella pneumoniaein onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
- (2016) Enrico Maria Trecarichi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
- (2016) Christopher Lucasti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity againstPseudomonas aeruginosa
- (2016) Akinobu Ito et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii
- (2016) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae
- (2016) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program
- (2016) Elizabeth Temkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
- (2016) Boudewijn L. M. de Jonge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance
- (2016) Ling-Shan Syue et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases
- (2016) Polydoros Tofas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline
- (2016) Yunliang Zhang et al. JOURNAL OF ANTIBIOTICS
- Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
- (2016) Oren Zusman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin
- (2016) Hung-Jen Tang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections
- (2016) Wentao Ni et al. MEDICINE
- Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
- (2016) Valerio Del Bono et al. Virulence
- Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae
- (2016) Joshua T. Thaden et al. Virulence
- Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
- (2015) Gabrielle A. Gibson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam Activity Tested against Enterobacteriaceae Isolates from U.S. Hospitals (2011 to 2013) and Characterization of β-Lactamase-Producing Strains
- (2015) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations
- (2015) Hervé Dupont et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
- (2015) Wentao Ni et al. Brazilian Journal of Infectious Diseases
- Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study
- (2015) D.R. Giacobbe et al. CLINICAL MICROBIOLOGY AND INFECTION
- Plazomicin: an investigational therapy for the treatment of urinary tract infections
- (2015) Ilias Karaiskos et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)
- (2015) KE Goodman et al. Expert Review of Anti-Infective Therapy
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitroevaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
- (2015) Laurent Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The β-Lactams Strike Back: Ceftazidime-Avibactam
- (2015) Evan J. Zasowski et al. PHARMACOTHERAPY
- Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management
- (2015) Keith S. Kaye et al. PHARMACOTHERAPY
- In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
- (2014) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
- (2014) Timothy A. Blizzard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011
- (2014) M J Dautzenberg et al. Eurosurveillance
- Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers
- (2013) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
- (2013) Matthew E. Falagas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae
- (2013) Dora E. Wiskirchen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients
- (2013) B. Balandin Moreno et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- KPC - 3 Klebsiella pneumoniaeST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients
- (2013) Paola Di Carlo et al. BMC Anesthesiology
- Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance
- (2013) Richard R. Watkins et al. Frontiers in Microbiology
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit
- (2012) F. Sbrana et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
- (2012) L. S. Tzouvelekis et al. CLINICAL MICROBIOLOGY REVIEWS
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
- (2011) G.L. Daikos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
- (2011) Matthew E Falagas et al. Future Microbiology
- What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
- (2011) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae
- (2010) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model
- (2010) M. Souli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China
- (2010) Yan Qi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- How antibiotics kill bacteria: from targets to networks
- (2010) Michael A. Kohanski et al. NATURE REVIEWS MICROBIOLOGY
- Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
- (2009) G. L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ACHN-490, a Neoglycoside with Potent In Vitro Activity Against Multidrug-Resistant Klebsiella pneumoniae Isolates
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
- (2009) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
- (2009) Andrea Endimiani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now